Clinical Trials on HCMV

Total 391 results

AiCuris Anti-infective Cures AG
Quintiles, Inc.

Completed

Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients

HCMV Reactivation or HCMV End-Organ Disease

United States, Germany
Novartis Pharmaceuticals

Completed

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

HCMV

Taiwan, Belgium, Germany, Singapore, United States, Korea, Republic of
St George's, University of London
St George's University Hospitals NHS Foundation Trust

Completed

Cytomegalovirus Shedding Characteristics in Pregnant Women (cCHIPS)

CMV | Congenital Cmv | Maternal Infections Affecting Fetus or Newborn | Shedding Virus

United Kingdom
Ain Shams University

Completed

Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV

HCV
Pfizer

Completed

Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects

HCV

United States
Grupo Espanol de trasplantes hematopoyeticos y...

Not yet recruiting

Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seropositive Donors: an Exploratory Study From Spanish GETH/TC Centers

CMV
QIAGEN Gaithersburg, Inc

Terminated

Clinical Evaluation of the QuantiFERON CMV Assay

CMV

United States
Ascletis Pharmaceuticals Co., Ltd.

Completed

Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China

HCV

China
Hadassah Medical Organization

Withdrawn

Adoptive Immunotherapy for CMV Disease

CMV Disease

Israel
Medical University of South Carolina
Takeda

Recruiting

Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients

CMV | Transplant Complication

United States
University Hospital, Limoges
University Hospital, Lille

Completed

Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant (TRANSFECMV)

Healthy Volunteers | CMV

France
Bristol-Myers Squibb

Completed

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

HCV (Genotype 1)

United States, Puerto Rico
Meridian Bioscience, Inc.

Completed

Detection of Cytomegalovirus Virus in Neonates (CMV)

CMV

United States, Australia, Canada, Italy
Virginia Commonwealth University
Merck Sharp & Dohme LLC

Recruiting

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip

CMV | Kidney Transplant; Complications

United States
Fundación para la Investigación del Hospital Clínico...

Completed

Pre-engraftment Cytomegalovirus DNAemia

CMV DNAemia Pre-engraftment

Spain
Imperial College London

Withdrawn

Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

Allogeneic Stem Cell Transplantation | CMV Reactivation | Autologous CMV Specific CD8+ T Cells

United Kingdom
Novartis Pharmaceuticals

Withdrawn

A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection

HCMV Infection
University of California, Irvine
Eurofins Viracor

Not yet recruiting

Prospect Eval of Efficacy of CMV-TCIP Direct Letermovir Prophylax After Allogen Hemato Cell Transpla

CMV | Allogeneic Stem Cell Transplantation

United States
Hospital Israelita Albert Einstein

Recruiting

Expansion of Virus-Specific Lymphocytes for Cell Therapy

CMV | CMV Viremia

Brazil
The Republican Research and Practical Center for...
Belarusian State Medical University

Enrolling by invitation

Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals

CMV

Belarus
University of Alabama at Birmingham

Recruiting

Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation (CMV)

Cmv Congenital | CMV Viremia

Brazil
St George's, University of London
European Society for Paediatric Infectious Diseases

Recruiting

Observational Study of the Management of Infants With Congenital CMV (cCMVnet)

Congenital Cmv

United Kingdom
AlloVir

Completed

Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)

CMV Infections

United States
Valme University Hospital
Boehringer Ingelheim

Unknown

Influence of Nevirapine on HCV Viral Load (HELICON)

HCV Infection. | HCV Viral Load.

Spain
New York Medical College

Recruiting

CMV CTLs in Neonates With CMV Infection

Congenital Cytomegaloviral (CMV) Disease

United States
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients (PREVENT-HCV)

HCV

United States
Tibotec Pharmaceuticals, Ireland

Completed

TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers

HCV
Merck Sharp & Dohme LLC

Completed

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Cytomegalovirus (CMV) Infections

United States, Australia, Canada, Finland, Israel, Russian Federation, Spain
University of Nebraska

Completed

Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit

Congenital CMV Infection

United States
Merck Sharp & Dohme LLC

Completed

Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)

CMV Disease

United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, France, Germany, Hungary, Italy, Mexico, New Zealand, Poland, Spain, United Kingdom
Lophius Biosciences GmbH

Completed

Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients (CMValue)

Kidney Transplantation | Cytomegalovirus | CMV Specific Immune Response

Germany
University of Nebraska

Withdrawn

Study of CMV in Kidney Transplant Recipients

CMV Viral Loads in Seropositive Renal Transplant Recipients

United States
Tel-Aviv Sourasky Medical Center
Merck Sharp & Dohme LLC

Unknown

the Effect of Grazoprevir/Elbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC. (ZEPATIER)

HCV, HCC
Albert Park
Genentech, Inc.; National Institute on Deafness and Other Communication Disorders...

Active, not recruiting

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants (ValEAR)

Cmv Congenital | CMV | Congenital Cmv | SNHL | Sensorineural Hearing Loss

United States
St. Jude Children's Research Hospital
Oxford Immunotec

Terminated

Evaluating the Clinical Utility of the T-SPOT.CMV Assay for the Prediction of CMV Reactivation Among Pediatric Patients Undergoing Hematopoietic Cell Transplant

CMV

United States
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb; National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV

HIV-HCV

United States
Gilead Sciences

Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV Infection

Chronic Genotype 4 HCV | Chronic Genotype 5 HCV

France
Institute of Hematology & Blood Diseases Hospital

Not yet recruiting

Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT

The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
Hookipa Biotech GmbH

Completed

A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients

Kidney Transplantation | Cytomegalovirus (CMV) Infection

United States, Denmark, Norway, United Kingdom, Germany, France
Assiut University

Unknown

Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases (RAVs)

HCV
Assistance Publique Hopitaux De Marseille

Unknown

Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients (HCURE)

HIV Associated HCV

France
Astellas Pharma Global Development, Inc.
Vical

Completed

A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor

Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients

United States, Australia, Canada, France, Germany, Spain
Assistance Publique - Hôpitaux de Paris
Gilead Sciences

Terminated

HCV, HBV, HIV Testing During Consultation With Anesthesiologist (SAHARA)

Hiv | HBV | HCV

France
Radboud University Medical Center

Withdrawn

Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet (CRUSADE-1)

HCV

Netherlands, Germany
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) (HELIOS)

Cytomegalovirus (CMV)-Positive Recipients | Allogeneic, Hematopoietic Cell Transplant (HCT)

Japan, Korea, Republic of, United States, Canada, Australia, Belgium, France, Germany, Spain, Sweden, Taiwan
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Recruiting

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

CMV | CMV Infection | Hematopoietic Cell Transplant

United States
Stony Brook University
Frontier Science & Technology Research Foundation, Inc.

Recruiting

Long-Term Outcomes of Children With Congenital CMV in New York State (PROACTIVE NYS)

Sensorineural Hearing Loss | Congenital CMV Infection

United States
Assiut University

Unknown

Very Rapid and Rapid Virological Response as Predictors of Response of HCV Tretment

Predictors of Response to HCV Tretment
Kirby Institute
Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM) and other collaborators

Recruiting

National Prisons Hepatitis Education Project: Research Evaluation (HepPEd)

HCV

Australia
Chinese PLA General Hospital

Recruiting

CMV-TCR-T Cells for CMV Infection After Allogenic HSCT

CMV Infection After Allogenic HSCT

China

Clinical Trials on HCMV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations